UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection

Journal of acquired immune deficiency syndromes (1999), 2018-06, Vol.78 (2), p.125-135

2018

Volltextzugriff (PDF)

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10101), p.1499-1510

2017

Volltextzugriff (PDF)

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (12), p.1124-1135

2020

Volltextzugriff (PDF)

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

AIDS (London), 2021-07, Vol.35 (9), p.1333-1342

2021

Volltextzugriff (PDF)

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (4), p.498-506

2020

Volltextzugriff (PDF)

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0170221-e0170221

2022

Volltextzugriff (PDF)

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study

Open forum infectious diseases, 2021-09, Vol.8 (9), p.ofab439-ofab439

2021

Volltextzugriff (PDF)

Effects of cattle manure and soil parent material on shallow groundwater quality

Agrosystems, geosciences & environment, 2023-09, Vol.6 (3), p.n/a

2023

Volltextzugriff (PDF)

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study

Open forum infectious diseases, 2022-04, Vol.9 (4), p.ofac067-ofac067

2022

Volltextzugriff (PDF)

Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2570-2575

2012

Volltextzugriff (PDF)

Aquifer lithology affects shallow groundwater quality more than nitrogen fertilizer form and placement method in an Iowa agricultural field

Agrosystems, geosciences & environment, 2021, Vol.4 (2), p.n/a

2021

Volltextzugriff (PDF)

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

AIDS (London), 2002-09, Vol.16 (14), p.1859-1866

2002

Volltextzugriff (PDF)

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

AIDS (London), 2013-07, Vol.27 (11), p.1771-1778

2013

Volltextzugriff (PDF)

Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance

AIDS research and human retroviruses, 2018-04, Vol.34 (4), p.343-346

2018

Volltextzugriff (PDF)

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4046-4051

2005

Volltextzugriff (PDF)

Dissolved phosphate concentrations in Iowa shallow groundwater

Journal of environmental quality, 2020-07, Vol.49 (4), p.909-920

2020

Volltextzugriff (PDF)

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

The Journal of infectious diseases, 2022-05, Vol.225 (10), p.1741-1749

2022

Volltextzugriff (PDF)

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3147-3154

2007

Volltextzugriff (PDF)

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of infectious diseases, 2022-12, Vol.226 (12), p.2170-2180

2022

Volltextzugriff (PDF)

Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4465-4473

2005

Volltextzugriff (PDF)

Subsurface Nitrate Processing Beneath Drainageways: Are They Landscape Opportunities for Subsurface Drainage Remediation?

Journal of the ASABE, 2022, Vol.65 (5), p.985-995

2022

Volltextzugriff (PDF)

Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review

Antiviral therapy, 2019-01, Vol.24 (6), p.393-404

2019

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(87)

Sprache

Englisch
(86)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(69)
Humans
(57)
Infectious Diseases
(47)
Biological And Medical Sciences
(39)
Hiv Infections - Drug Therapy
(37)
Medical Sciences
(35)
Aids/hiv
(31)
Immunology
(31)
Microbiology
(28)
Virology
(27)
Hiv
(26)
Anti-Hiv Agents - Therapeutic Use
(25)
Antiviral Agents
(24)
Human Immunodeficiency Virus
(24)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(22)
Female
(22)
Hiv Infections - Virology
(22)
Hiv-1 - Drug Effects
(22)
Hiv-1 - Genetics
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study

Effects of cattle manure and soil parent material on shallow groundwater quality

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study

Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects

Aquifer lithology affects shallow groundwater quality more than nitrogen fertilizer form and placement method in an Iowa agricultural field

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor

Dissolved phosphate concentrations in Iowa shallow groundwater

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance

Subsurface Nitrate Processing Beneath Drainageways: Are They Landscape Opportunities for Subsurface Drainage Remediation?

Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review

Suchergebnisse filtern